Table 1 Demographic and baseline characteristic data of study patients
Variables | Peg-IFNα-2a (n = 43) | Peg-IFNα-2a + ETV (n = 49) | Peg-IFNα-2a + ADV (n = 46) | P value |
|---|---|---|---|---|
Age | 34.86 ± 10.86 | 37.38 ± 9.51 | 38.63 ± 9.98 | 0.188 |
Sex, males (%) | 24 (55.8%) | 35 (71.4%) | 31 (67.4%) | 0.272 |
Baseline HBV DNA, (log10copies/mL) | 6.47 ± 1.16 | 6.48 ± 1.01 | 6.24 ± 1.14 | 0.513 |
Baseline ALT, U/L | 102 (87, 159) | 119 (85, 162) | 105 (87.8, 197.8) | 0.744 |
HBeAg status | 0.905 | |||
positive | 28 (65.1%) | 33 (67.3%) | 32 (69.6%) | |
negative | 15 (34.9%) | 16 (32.7%) | 14 (30.4%) | |
Genotype | 0.183 | |||
B | 10 (23.8%) | 14 (28.6%) | 19 (41.3%) | |
C | 32 (76.2%) | 35 (71.4%) | 27 (58.7%) |